To explore the mechanism associated with ERRβ downregulation, we first analyzed the transcript levels of ERRβ in a non-tumorigenic epithelial cell line (MCF10A), two ER-positive (MCF7 and T47D) and a triple-negative (MDA-MB-231) breast cancer cell lines. The gene discussed is ESR1; the disease is breast carcinoma.